Day: January 4, 2021

Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 4, 2021. Posted in Public Companies.

WAYNE, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 8:20 a.m. (ET).A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

Centerra Gold Announces New Corporate Credit Facility

Written by Customer Service on January 4, 2021. Posted in Public Companies.

TORONTO, Jan. 04, 2021 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra”) (TSX: CG) announced today it has entered into a new U.S.$400 million four-year revolving credit facility plus a U.S.$200 million accordion feature (the “Credit Facility”). The Credit Facility is led by The Bank of Nova Scotia, National Bank Financial Markets and HSBC Canada Bank and is supported by a syndicate of international financial institutions. The interest rate payable on any outstanding borrowings is LIBOR plus 2.25% to 3.25%. The Credit Facility replaced Centerra’s previous U.S.$500 million revolving credit facility.The Credit Facility is currently undrawn and may be used for general corporate purposes, including working capital, investments, acquisitions, and capital expenditures. The Credit Facility provides future flexibility, while...

Emergent BioSolutions to Participate in Investor Conferences

Written by Customer Service on January 4, 2021. Posted in Public Companies.

GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2021:39th Annual J.P. Morgan Healthcare ConferenceJanuary 11 to 14, 2021Company presentation scheduled on January 11 at 8:20am ESTJ.P. Morgan 2021 Global High Yield & Leveraged Finance ConferenceMarch 1 to 3, 2021Presentation date and time will be updated on the Emergent website as the information becomes available.Cowen 41st Annual Health Care ConferenceMarch 1 to 4, 2021Presentation date and time will be updated on the Emergent website as the information becomes available.For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the...

ORIC Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 4, 2021. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob Chacko, M.D., chief executive officer, will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 12:40 p.m. PT. A live webcast will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.About ORIC Pharmaceuticals, Inc.ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s lead product candidate, ORIC-101, is a potent...

Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates

Written by Customer Service on January 4, 2021. Posted in Public Companies.

Data confirm delivery of closed-ended DNA to the liver via novel, cell-targeted lipid nanoparticlesWell tolerated at all dose levels in mice and non-human primatesCompany on track to select development candidate for hemophilia A and begin IND-enabling studies this year, submit IND in 2022Webcast and conference call to be held today at 8:00 a.m. ESTCAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced data today from a study achieving tolerability and targeted factor VIII expression levels in hemophilia A mice with a single dose of closed-ended DNA (ceDNA) delivered via the company’s novel, cell-targeted lipid nanoparticle (ctLNP) system. In this study, conducted with a ceDNA development construct, a...

Eezy’s divestment of its subsidiary in Sweden has been completed

Written by Customer Service on January 4, 2021. Posted in Public Companies.

EEZY OYJ — INVESTOR NEWS — 4 JANUARY 2021 AT 13.30Eezy’s divestment of its subsidiary in Sweden has been completedEezy has today completed the divestment of its Swedish subsidiary VMP-Group Sweden AB to Palm & Partners Bemanning AB, which divestment was announced in December 2020.After the transaction Eezy’s revenue is fully generated in Finland.For further information, please contact:Sami AsikainenCEOsami.asikainen@eezy.fitel. +358 (0)40 700 9915Hannu NymanCFOhannu.nyman@eezy.fitel. +358 (0)50 306 9913

Eezyn Ruotsin tytäryhtiön myynti on toteutunut

Written by Customer Service on January 4, 2021. Posted in Public Companies.

EEZY OYJ — SIJOITTAJAUUTINEN — 4.1.2021 KLO 13.30Eezyn Ruotsin tytäryhtiön myynti on toteutunutEezyn Ruotsin tytäryhtiön VMP-Group Sweden AB:n joulukuussa 2020 tiedotettu myynti Palm & Partners Bemanning AB:lle on toteutunut tänään.Kaupan jälkeen Eezyn liikevaihto syntyy kokonaan Suomessa.Lisätietoja:Sami Asikainentoimitusjohtajasami.asikainen@eezy.fipuh. +358 (0)40 700 9915Hannu Nymantalousjohtajahannu.nyman@eezy.fipuh. +358 (0)50 306 9913

Brown & Brown, Inc. Announces the Asset Acquisition of Berry Insurance Group

Written by Customer Service on January 4, 2021. Posted in Mergers And Acquisitions.

DAYTONA BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and Mark Berry, the owner of Berry Insurance Group, today announced that Brown & Brown of Ohio, LLC, a subsidiary of Brown & Brown, Inc., has acquired substantially all of the assets of Berry Insurance Group.Founded in 2002 by Mark Berry, Berry Insurance Group has grown to one of the most prominent insurance brokerage agencies in the Ohio, providing commercial and personal insurance products for business and individual customers throughout the Cincinnati tri-state area. Mark Berry will continue to lead the Berry Insurance Group team operating from their offices in Terrace Park and Lebanon, Ohio. Mark will report to Tommy Huval, Regional President of Brown & Brown Retail.Tommy Huval...

Brown & Brown, Inc. Announces the Asset Acquisition of ADM Marketing Group, Inc. and ADM Insurance Services, Ltd. by Brown & Brown Dealer Services

Written by Customer Service on January 4, 2021. Posted in Mergers And Acquisitions.

DAYTONA BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and Harold (Howie) E. Haldeman, the owner of ADM Marketing Group, Inc. and its affiliate ADM Insurance Services, Ltd. (collectively, ADM), today announced that Brown & Brown Dealer Services (BBDS) has acquired substantially all of the assets of ADM.Founded in 1987, ADM is an independent sales and service organization providing F&I products and sales support to automotive and powersport dealers in the Northeast and Mid-Atlantic. Following the transaction, the ADM team will continue doing business from their existing location in Camp Hill, Pennsylvania, and will become part of BBDS, which operates under the leadership of Mike Neal.Mr. Neal stated, “Howie and his team have built one of...

Dentsply Sirona Acquires Byte®, a Leading Direct-to-Consumer, Doctor-Directed Clear Aligner Company

Written by Customer Service on January 4, 2021. Posted in Mergers And Acquisitions.

Enhances scale in the important clear aligner spaceAccelerates the growth and profitability of Dentsply Sirona’s combined clear aligners businessAccretive to Dentsply Sirona’s long-term financial targets and Non-GAAP EPS in 2021Dentsply Sirona to host investor call at 8:30 am ET on January 4, 2021CHARLOTTE, N.C. and LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), and Byte, a rapidly growing clear aligner company, today announced that Dentsply Sirona acquired Byte in an all-cash deal for $1.04 billion. Byte holds a leadership position in the rapidly growing direct-to-consumer, doctor-directed clear aligner market. As a result of the transaction, Dentsply Sirona adds scale to its SureSmile® clear aligner business and strengthens its connection with dental professionals. With the...

Day: January 4, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals